Stifel Financial
DFTX

Stifel Financial’s Definium Therapeutics DFTX Stock Holding History

Stifel Financial’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$239K Buy
+12,626
New +$214K ﹤0.01% 3322
2022
Q2 		– Sell
-3,316
Closed -$56K – 3417
2022
Q1 		$56K Buy
3,316
+233
+8% +$4.04K ﹤0.01% 3302
2021
Q4 		$64K Buy
3,083
+84
+3% +$2.68K ﹤0.01% 3293
2021
Q3 		$105K Buy
2,999
+16
+0.5% +$692 ﹤0.01% 3238
2021
Q2 		$154K Buy
+2,983
New +$157K ﹤0.01% 3188

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Stifel Financial's DFTX Position: Q1 2026 in Review

Stifel Financial opened a new position in Definium Therapeutics (DFTX) in Q1 2026: 12,626 shares worth $239K. The stake represents ﹤0.01% of the portfolio and ranks #3322 among its holdings. This is a return to the name: Stifel Financial previously reported a position in DFTX as recently as Q1 2022.

Stifel Financial first reported a position in DFTX in Q2 2021 and has held it in 5 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Stifel Financial held 12,626 shares of Definium Therapeutics worth $239K as of Q1 2026.
  • Definium Therapeutics was a new Stifel Financial position in Q1 2026.
  • Definium Therapeutics made up ﹤0.01% of Stifel Financial's portfolio in Q1 2026, its #3322 holding.
  • Stifel Financial first reported a position in Definium Therapeutics in Q2 2021 and has held it in 5 quarters since.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.